Back to top
more

Better trading starts here.

Brokerage Reports

Research for CTLT

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

1 item in cart

View Cart/Checkout

Catalent, Inc. [CTLT]

Reports for Purchase

Showing records 121 - 140 ( 217 total )

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 121

02/23/2021

Industry Report

Pages: 6

Life Science Tools: Hard and Soft Landings for COVID-19 Diagnostics and Vaccines

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 122

02/02/2021

Daily Note

Pages: 11

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 123

02/02/2021

Company Report

Pages: 9

Higher Growth at a Discount; Raise PT from $120 to $142

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 124

01/27/2021

Industry Report

Pages: 3

Bioproduction: ''Guten Morgan Europe'' - Positive 2021 Industry Guides from Lonza and Sartorius

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 125

01/15/2021

Industry Report

Pages: 3

Life Science Tools: DC Never Friendlier with Biden "American Rescue Plan"

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 126

01/15/2021

Industry Report

Pages: 3

D.C. Very Friendly with Biden "American Rescue Plan";

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 127

01/08/2021

Daily Note

Pages: 5

Tech Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 128

01/08/2021

Daily Note

Pages: 6

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 129

12/22/2020

Daily Note

Pages: 10

Modeling COVID-19: Vaccine and Diagnostic Demand Outlook with Herd Immunity in 2021

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 130

12/10/2020

Daily Note

Pages: 9

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 131

12/10/2020

Daily Note

Pages: 5

Tech Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 132

12/09/2020

Company Report

Pages: 14

Assuming Co-Coverage and Upgrading to OW: ''Thermoesque'' Biologics Transformation

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 133

11/24/2020

Daily Note

Pages: 9

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 134

11/24/2020

Daily Note

Pages: 6

Tech Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 135

11/23/2020

Daily Note

Pages: 33

CROs/CDMOs: Looking Forward (Post-3Q20)

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 75.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 136

08/31/2020

Daily Note

Pages: 5

Research Summary

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 137

08/31/2020

Company Report

Pages: 6

Tailwinds Everywhere

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 25.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 138

08/18/2020

Daily Note

Pages: 8

Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 139

08/18/2020

Daily Note

Pages: 5

Tech Morning Call

Provider: KEYBANC CAPITAL MARKETS

Analyst: Research Department

Price: 10.00

Research Provided by a Third Party

Company: Catalent, Inc.

Industry: Medical - Drugs

Record: 140

08/17/2020

Daily Note

Pages: 32

CROs/CDMOs: The Road Map Ahead (Post-2Q20)

Provider: KEYBANC CAPITAL MARKETS

Analyst: HOOKER D

Price: 75.00

Research Provided by a Third Party